Equities research analysts forecast that Nutrien Ltd (NYSE:NTR) will report $0.27 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Nutrien’s earnings. The highest EPS estimate is $0.32 and the lowest is $0.17. Nutrien posted earnings per share of $0.54 during the same quarter last year, which would suggest a negative year-over-year growth rate of 50%. The business is expected to announce its next earnings report on Wednesday, February 5th.
According to Zacks, analysts expect that Nutrien will report full-year earnings of $2.32 per share for the current year, with EPS estimates ranging from $2.20 to $2.40. For the next year, analysts expect that the company will post earnings of $2.90 per share, with EPS estimates ranging from $2.35 to $3.25. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for Nutrien.
Nutrien (NYSE:NTR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.12). The firm had revenue of $4.13 billion for the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a return on equity of 6.49% and a net margin of 20.95%. The company’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.47 earnings per share.
Large investors have recently bought and sold shares of the business. National Pension Service bought a new position in Nutrien in the second quarter worth about $69,931,000. Hexavest Inc. increased its position in Nutrien by 2,931.9% during the fourth quarter. Hexavest Inc. now owns 903,625 shares of the company’s stock worth $43,322,000 after acquiring an additional 873,821 shares during the period. Mackenzie Financial Corp increased its position in Nutrien by 11.3% during the second quarter. Mackenzie Financial Corp now owns 8,580,722 shares of the company’s stock worth $458,725,000 after acquiring an additional 872,389 shares during the period. Nuveen Asset Management LLC bought a new position in Nutrien during the second quarter worth about $46,240,000. Finally, Beutel Goodman & Co Ltd. increased its position in Nutrien by 5.7% during the second quarter. Beutel Goodman & Co Ltd. now owns 13,435,410 shares of the company’s stock worth $718,661,000 after acquiring an additional 718,508 shares during the period. 63.88% of the stock is owned by institutional investors.
Shares of NTR stock traded down $0.51 on Friday, reaching $47.43. 26,808 shares of the stock were exchanged, compared to its average volume of 1,032,403. The stock has a market cap of $27.46 billion, a P/E ratio of 17.61, a price-to-earnings-growth ratio of 2.09 and a beta of 0.90. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.41. The firm has a 50 day moving average of $47.57 and a two-hundred day moving average of $49.59. Nutrien has a 1-year low of $45.82 and a 1-year high of $56.00.
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 16th. Investors of record on Tuesday, December 31st will be issued a $0.45 dividend. The ex-dividend date of this dividend is Monday, December 30th. This represents a $1.80 annualized dividend and a yield of 3.80%. Nutrien’s dividend payout ratio is currently 66.91%.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.